Research Excellence Award
Nicola Cosentino
Centro Cardiologico Monzino, Italy
Nicola Cosentino is an Italian physician-scientist and cardiovascular researcher affiliated with Centro Cardiologico Monzino, Milan, Italy. His scholarly work has contributed extensively to the understanding of acute myocardial infarction, cardiovascular inflammation, cardio-renal interactions, translational cardiology, and precision medicine approaches in coronary artery disease. Through multidisciplinary collaborations, clinical investigations, and translational research programs, Cosentino has contributed to the advancement of cardiovascular diagnostics, biomarker discovery, and prognostic stratification methodologies in modern clinical cardiology.[1]
He has authored and co-authored more than 150 peer-reviewed scientific publications indexed in major international databases and has participated in several multicenter clinical trials and international cardiovascular initiatives. His research activities integrate acute cardiovascular care, heart failure management, metabolic disorders, inflammation biology, and innovative therapeutic strategies associated with cardiovascular and neurological complications.[2]
Abstract
The academic and clinical contributions of Nicola Cosentino are associated with contemporary developments in cardiovascular medicine, translational cardiology, and interdisciplinary biomedical sciences. His research portfolio demonstrates sustained engagement in acute coronary syndrome management, inflammatory biomarkers, cardiovascular imaging, metabolic dysfunction, acute kidney injury, and heart failure pathophysiology. Through collaborations with major cardiovascular institutions and international scientific groups, his work has contributed to improved understanding of prognostic indicators and therapeutic strategies relevant to cardiovascular and neurovascular disease mechanisms.[3]
Keywords
Cardiovascular Medicine, Translational Cardiology, Acute Myocardial Infarction, Neurocardiology, Precision Medicine, Heart Failure, Biomarkers, Acute Coronary Syndrome, Cardiovascular Inflammation, Cardio-Renal Syndrome, Clinical Research, Neuroscience Innovation, Cardiovascular Imaging, Metabolic Disorders, Intensive Cardiac Care.
Introduction
Nicola Cosentino graduated in Medicine with highest honors from the Catholic University of the Sacred Heart in Rome and subsequently specialized in cardiology while pursuing advanced translational medical research. His clinical and academic activities have been centered at Centro Cardiologico Monzino IRCCS in Milan, where he has held several positions related to intensive cardiac care, acute coronary syndrome management, and perioperative cardiology.[4]
His academic background combines clinical cardiology, translational medicine, biomarker research, and multidisciplinary therapeutic approaches. Over time, his work has increasingly incorporated emerging intersections between cardiovascular disease mechanisms and broader systemic pathophysiological processes, including inflammatory signaling, endothelial dysfunction, and organ interaction pathways relevant to neuroscience and vascular biology.[5]
Research Profile
Cosentino’s research profile reflects substantial scholarly productivity and international scientific engagement. His publication record includes peer-reviewed articles in journals such as European Heart Journal, JACC, International Journal of Cardiology, Cardiovascular Diabetology, Scientific Reports, and Journal of Clinical Medicine.[6]
His work frequently addresses clinical outcomes in myocardial infarction, diabetes-associated cardiovascular complications, platelet activation, inflammatory biomarkers, renal dysfunction, cardiovascular imaging, and translational therapeutic strategies. He has additionally participated in multicenter studies such as PROMISE, MATADOR-PCI, REOPEN-AMI, and AEGIS II, contributing to evidence-based cardiovascular practice and translational cardiovascular medicine.[7]
- More than 150 peer-reviewed scientific publications.
- h-index of 30 according to Scopus metrics.
- Extensive contributions to acute coronary syndrome and heart failure research.
- Participation in international multicenter cardiovascular trials.
- Editorial and peer-review responsibilities in international biomedical journals.
Research Contributions
A major aspect of Cosentino’s scientific activity concerns acute myocardial infarction and associated cardiovascular complications. His investigations into inflammation, mitochondrial biomarkers, platelet activation, renal injury, and glycemic variability have contributed to the refinement of risk stratification frameworks in acute cardiac care.[8]
His work has also explored mechanistic pathways involving oxidative stress, endothelial dysfunction, macrophage biology, thrombosis, and vascular inflammation. These investigations have relevance not only for cardiovascular disease but also for emerging translational connections involving neurovascular and systemic inflammatory pathways associated with neurological disorders.[9]
In addition, Cosentino has contributed to clinical studies related to diabetes mellitus, chronic kidney disease, cardiorenal interactions, and cardiovascular outcomes associated with metabolic dysfunction. Several of these studies have evaluated long-term prognostic indicators and precision medicine strategies for individualized cardiovascular care.[10]
- Research on acute coronary syndromes and myocardial infarction.
- Investigations involving inflammatory and mitochondrial biomarkers.
- Studies on platelet activation and endothelial dysfunction.
- Clinical evaluation of cardio-renal interactions.
- Contributions to translational cardiovascular medicine and precision cardiology.
Publications
Selected representative publications authored or co-authored by Nicola Cosentino include major contributions in cardiovascular medicine, translational biology, and clinical cardiology.[11]
- Cosentino N, Trombara F, De Metrio M, et al. Cardiovascular Protection in Coronary Artery Disease: Mechanistic and Clinical Insights into SGLT2 Inhibitors and GLP-1 Receptor Agonists. Pharmaceuticals (Basel), 2025.
- Cosentino N, Campodonico J, Milazzo V, et al. Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications. Journal of Clinical Medicine, 2021.
- Brambilla M, Becchetti A, Rovati GE, Cosentino N, et al. Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity. Arteriosclerosis, Thrombosis, and Vascular Biology, 2023.
- Cosentino N, Campodonico J, Moltrasio M, et al. High-Sensitivity C-Reactive Protein and Acute Kidney Injury in Patients with Acute Myocardial Infarction. Journal of Clinical Medicine, 2019.
- Marenzi G, Cosentino N, Bartorelli AL. Acute Kidney Injury in Patients with Acute Coronary Syndromes. Heart, 2015.
Research Impact
The research impact associated with Nicola Cosentino is reflected through citation metrics, interdisciplinary collaborations, clinical translational outcomes, and participation in international scientific initiatives. His publications have been cited extensively in cardiovascular and translational medicine literature, particularly in areas related to myocardial infarction, inflammatory signaling, cardiovascular biomarkers, and acute cardiac care.[12]
His scientific work has additionally contributed to evolving perspectives concerning vascular inflammation, systemic metabolic dysregulation, and organ interaction pathways relevant to neurological and cardiovascular disease progression. These multidisciplinary dimensions support the relevance of his research within emerging neuroscience-related biomedical fields.[13]
- Scopus h-index of 30.
- Nearly 3,000 scholarly citations.
- International collaborations in cardiovascular medicine.
- Editorial responsibilities in peer-reviewed scientific journals.
- Research grants awarded by major scientific organizations and national institutions.
Award Suitability
Nicola Cosentino’s academic profile demonstrates sustained excellence in translational cardiovascular research, clinical innovation, and interdisciplinary biomedical investigation. His extensive publication record, clinical leadership roles, scientific collaborations, and contributions to acute cardiovascular medicine collectively support recognition within the framework of the World Neuroscientists Awards.[14]
His work reflects scientific rigor, translational relevance, and long-term contributions to patient-centered cardiovascular research. Furthermore, the integration of inflammation biology, vascular dysfunction, metabolic signaling, and organ-system interactions establishes meaningful relevance to contemporary neuroscience and neurovascular medicine research directions.[15]
Conclusion
Nicola Cosentino has established a substantial academic and clinical research profile characterized by interdisciplinary cardiovascular investigation, translational medicine contributions, and international scientific collaboration. His scholarly work has contributed to improved understanding of myocardial infarction, inflammatory cardiovascular disease, biomarker-guided prognosis, and cardio-renal interactions. The breadth and scientific consistency of his contributions support his recognition in international academic and biomedical award frameworks associated with neuroscience and translational medicine.[16]
External Links
References
- Elsevier. (n.d.). Scopus author details: Nicola Cosentino, Author ID 6602546905. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=6602546905
- ORCID. (n.d.). Nicola Cosentino ORCID profile.
https://orcid.org/0000-0002-8628-3106
- Cosentino N, et al. (2025). Cardiovascular Protection in Coronary Artery Disease: Mechanistic and Clinical Insights into SGLT2 Inhibitors and GLP-1 Receptor Agonists.
https://doi.org/10.3390/ph18081202
- Centro Cardiologico Monzino. (n.d.). Clinical and academic activities of Nicola Cosentino.
- Cosentino N, et al. (2021). Vitamin D and Cardiovascular Disease: Current Evidence and Future Perspectives. Nutrients.
https://doi.org/10.3390/nu13103603
- Journal Citation Reports. (n.d.). Indexed journals featuring cardiovascular and translational medicine publications.
- Montone RA, Cosentino N, et al. (2022). Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial.
- Cosentino N, et al. (2021). Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications.
https://doi.org/10.3390/jcm10020275
- Brambilla M, et al. (2024). Low-Grade Inflammation in Long COVID Syndrome Sustains a Persistent Platelet Activation Associated With Lung Impairment.
- Marenzi G, Cosentino N, et al. (2019). Reduced Cardiorenal Function Accounts for Most of the In-Hospital Morbidity and Mortality Risk Among Patients With Type 2 Diabetes Undergoing Primary Percutaneous Coronary Intervention.
https://doi.org/10.2337/dc19-0047
- PubMed. (n.d.). Publication records for Nicola Cosentino.
https://pubmed.ncbi.nlm.nih.gov/
- Scopus Analytics. (n.d.). Citation overview and research metrics for Nicola Cosentino.
https://www.scopus.com/
- Falcão-Pires I, et al. (2024). Mechanisms of myocardial reverse remodelling and its clinical significance.
- World Neuroscientists Awards. (n.d.). International scientific recognition and award program.
World Neuroscientists Awards
- Cosentino N, et al. (2023). Fluid balance in heart failure.
- Curriculum Vitae and academic publication records of Nicola Cosentino, Centro Cardiologico Monzino.
https://www.cardiologicomonzino.it/